24 HOUR WU ALLOCATION
| Research | Percent |
|---|---|
|
PEPTIDOMIMETIC CD40L BINDING |
57.14% |
|
ENZYME DYNAMICS |
41.56% |
|
ALZHEIMERS |
1.3% |
7 DAY WU ALLOCATION
| Research | Percent |
|---|---|
|
PEPTIDOMIMETIC CD40L BINDING |
44.13% |
|
ENZYME DYNAMICS |
38.07% |
|
CANCER |
7.58% |
|
SUCROSE TRANSPORTER ATSUC1 |
5.49% |
|
ALZHEIMERS |
4.73% |
12 WEEK WU ALLOCATION
| Research | Percent |
|---|---|
|
ENZYME DYNAMICS |
35.28% |
|
PEPTIDOMIMETIC CD40L BINDING |
23.39% |
|
CANCER |
21.27% |
|
ATGPA1 POST TRANSLATIONAL MODIFICATIONS |
12.36% |
|
ATGPA1 POST TRANSLATIONAL MODIFICATION DYNAMICS |
2.82% |
|
ALZHEIMERS |
2.31% |
|
SUCROSE TRANSPORTER ATSUC1 |
1.05% |
|
ATSTP10 TRANSPORT SIMULATION |
.67% |
|
MEMBRANE TRANSPORT |
.35% |
|
NIPAH VIRUS DECOY PROTEIN DYNAMICS |
.22% |
|
ATSTP10 SUCROSE TRANSPORT |
.22% |
|
NIPAH VIRUS DECOY PROTEINS |
.06% |